Panmure Gordon reiterated their buy rating on shares of Sphere Medical Holding PLC (LON:SPHR) in a research note issued to investors on Friday morning. Panmure Gordon currently has a GBX 17 ($0.22) price objective on the stock.
Shares of Sphere Medical Holding PLC (LON:SPHR) opened at 11.50 on Friday. The stock has a 50 day moving average price of GBX 11.79 and a 200-day moving average price of GBX 11.02. The firm’s market cap is GBX 16.30 million. Sphere Medical Holding PLC has a 1-year low of GBX 6.00 and a 1-year high of GBX 15.00.
Sphere Medical Holding PLC Company Profile
Sphere Medical Holding PLC is a United Kingdom-based Company specializing in the development of medical monitoring and diagnostic equipment. The Company’s products include Proxima and Pelorus. Proxima is an arterial blood gas analyser which supports rapid and frequent measurement. It is operated using the dedicated bedside monitor with touch screen interface.
Receive News & Ratings for Sphere Medical Holding PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sphere Medical Holding PLC and related companies with MarketBeat.com's FREE daily email newsletter.